Cognitive, urinary, and functional trajectories of older women using pharmacologic treatment strategies for urgency incontinence
使用药物治疗策略治疗急迫性尿失禁的老年女性的认知、泌尿和功能轨迹
基本信息
- 批准号:10563201
- 负责人:
- 金额:$ 90万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-15 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAdrenergic AgentsAdverse effectsAgeAgonistAlzheimer&aposs disease related dementiaAnti-CholinergicsBehavioralBladderBladder ControlChronicCognitionCognitiveCommunitiesConfusionCounselingDataDecision MakingDementiaDetectionDiagnosisDouble-blind trialDrug PrescriptionsElderlyEquilibriumEvaluationFractureFrequenciesHealth care facilityImpaired cognitionIncontinenceIndependent LivingIndustryIntestinesInvestigationLinkLong-Term CareMeasuresMental DepressionMethodologyObservational StudyOutcomeOveractive BladderParticipantPatientsPerformancePharmaceutical PreparationsPharmacological TreatmentPharmacotherapyPhysical FunctionPlacebosQuality of lifeRandomizedReportingResearchRiskSeveritiesSleepSocial isolationSymptomsSystemTestingTolterodineUnited StatesUrinary IncontinenceWomancognitive functioncognitive performancecognitive testingcomorbiditycomparativedesignevidence baseexperiencefallsfunctional declinefunctional outcomesimprovedimprovement on sleepmicturition urgencymild cognitive impairmentneglectolder patientolder womenpharmacologicpreservationprospectivepsychologicscreeningtreatment effecttreatment strategytrendurinary
项目摘要
PROJECT SUMMARY
One in five women over the age of 60 suffers from urgency incontinence, a condition associated with
depression, social isolation, physical function decline, and loss of ability to live independently. Currently, the
most commonly used treatments for urgency incontinence are anticholinergic medications designed to
suppress involuntary contractions of the bladder. Unfortunately, multiple observational studies have suggested
that anticholinergic bladder therapy may have adverse effects on cognition, based on higher rates of
diagnosed dementia in older patients prescribed these medications. As a result, there is widespread concern
that older incontinent patients who take anticholinergic medications in the hopes of improving their bladder
control may be exposing themselves to greater risk of functional compromise due to cognitive impairment.
To date, however, the data linking anticholinergic bladder medications with dementia are derived from
retrospective observational analyses rather than prospective trials. The few (and primarily industry-sponsored)
studies directly assessing cognitive function in older adults using anticholinergic bladder therapy have been
small and short and have used relatively insensitive cognitive screening measures, limiting their ability to
detect meaningful changes in cognition. While an alternate, non-anticholinergic medication for incontinence
(the beta-3-agonist drug mirabegron) is now available, very little research has compared the effects of this
medication to that of anticholinergic bladder therapy, and none has involved comparative prospective
assessments of cognition in older adults. In the absence of rigorous evidence of adverse cognitive effects,
anticholinergic bladder medications continue to be widely prescribed to older patients in the community,
including those with known cognitive impairment, Alzheimer’s disease, and related dementias.
To address this issue, we will conduct a rigorous, prospective, randomized study to evaluate extended
cognitive, urinary, and functional trajectories in ~270 older incontinent women without pre-existing dementia.
Women with frequent urgency incontinence and normal or mildly impaired cognitive function at baseline will be
assigned to receive standard anticholinergic, beta-3 agonist, or no pharmacologic treatment (placebo) in
addition to patient-directed, evidence-based information about behavioral management of incontinence. Over
1, 6, and 9 months, we will compare cognitive, urinary, and other functional and quality-of-life outcomes of
anticholinergic therapy in comparison to beta-3-agonist therapy and placebo. This research address the urgent
need for rigorous evidence to determine the effects of pharmacologic incontinence treatment strategies on both
cognitive impairment and incontinence, as two of the most common (and frequently comorbid) conditions that
cause older women to transition from living independently to entering long-term care facilities.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alison Huang其他文献
Alison Huang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alison Huang', 18)}}的其他基金
Letrozole for Treatment of Uterine Fibroids: A randomized, placebo-controlled trial
来曲唑治疗子宫肌瘤:一项随机、安慰剂对照试验
- 批准号:
10718036 - 财政年份:2023
- 资助金额:
$ 90万 - 项目类别:
Promoting Clinical and Translational Science Training and Career Development for Residents
促进住院医师的临床和转化科学培训和职业发展
- 批准号:
10598346 - 财政年份:2023
- 资助金额:
$ 90万 - 项目类别:
Cognitive, urinary, and functional trajectories of older women using pharmacologic treatment strategies for urgency incontinence
使用药物治疗策略治疗急迫性尿失禁的老年女性的认知、泌尿和功能轨迹
- 批准号:
10343015 - 财政年份:2022
- 资助金额:
$ 90万 - 项目类别:
Language-Concordant Mobile Health Training and Support for Behavioral Management of Urinary Incontinence for Women with Limited English Proficiency
为英语水平有限的女性提供语言一致的移动健康培训和尿失禁行为管理支持
- 批准号:
10772574 - 财政年份:2022
- 资助金额:
$ 90万 - 项目类别:
Cognitive, urinary, and functional trajectories of older women using pharmacologic treatment strategies for urgency incontinence Administrative supplement
使用药物治疗策略治疗急迫性尿失禁的老年女性的认知、泌尿和功能轨迹行政补充
- 批准号:
10635598 - 财政年份:2022
- 资助金额:
$ 90万 - 项目类别:
Promoting Multidisciplinary Clinical and Translational Science in Aging by Resident Investigators
常驻研究人员促进老龄化领域的多学科临床和转化科学
- 批准号:
10333347 - 财政年份:2021
- 资助金额:
$ 90万 - 项目类别:
Promoting Multidisciplinary Clinical and Translational Science in Aging by Resident Investigators
常驻研究人员促进老龄化领域的多学科临床和转化科学
- 批准号:
10557121 - 财政年份:2021
- 资助金额:
$ 90万 - 项目类别:
Midcareer Mentoring in Patient-Oriented Research on Genitourinary Aging in Women
以患者为导向的女性泌尿生殖系统衰老研究中的职业生涯中期指导
- 批准号:
10040999 - 财政年份:2020
- 资助金额:
$ 90万 - 项目类别:
A Feasibility Trial of a Group Based Yoga Intervention for Chronic Pelvic Pain in Women
基于团体的瑜伽干预治疗女性慢性盆腔疼痛的可行性试验
- 批准号:
10402278 - 财政年份:2020
- 资助金额:
$ 90万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 90万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 90万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 90万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 90万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 90万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 90万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 90万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 90万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 90万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 90万 - 项目类别:
Research Grant